Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2020-2026

世界の炎症性腸疾患(IBD)治療市場2026:インサイト・予測

◆タイトル:Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV12375
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:95
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥631,800見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは炎症性腸疾患(IBD)治療の世界市場について調査・分析した資料です。種類別(TNF阻害剤、アミノサリチル酸塩、免疫調節剤、コルチコステロイド)の市場規模、用途別(病院薬局、小売薬局、オンライン薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別炎症性腸疾患(IBD)治療の競争状況、市場シェア
・世界の炎症性腸疾患(IBD)治療市場:種類別市場規模 2015年-2020年(TNF阻害剤、アミノサリチル酸塩、免疫調節剤、コルチコステロイド)
・世界の炎症性腸疾患(IBD)治療市場:種類別市場規模予測 2021年-2026年(TNF阻害剤、アミノサリチル酸塩、免疫調節剤、コルチコステロイド)
・世界の炎症性腸疾患(IBD)治療市場:用途別市場規模 2015年-2020年(病院薬局、小売薬局、オンライン薬局)
・世界の炎症性腸疾患(IBD)治療市場:用途別市場規模予測 2021年-2026年(病院薬局、小売薬局、オンライン薬局)
・北米の炎症性腸疾患(IBD)治療市場分析:米国、カナダ
・ヨーロッパの炎症性腸疾患(IBD)治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの炎症性腸疾患(IBD)治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の炎症性腸疾患(IBD)治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの炎症性腸疾患(IBD)治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AbbVie、Pfizer、Takeda、Janssen Biotech, Inc. (Johnson & Johnson)、Allergan、Bausch Health、Takeda Pharmaceutical、Novartis、Biogen Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.
The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.

Market Analysis and Insights: Global Inflammatory Bowel Disease (IBD) Treatment Market
The global Inflammatory Bowel Disease (IBD) Treatment market size is projected to reach US$ 13640 million by 2026, from US$ 13310 million in 2020, at a CAGR of 2.3%% during 2021-2026.

Global Inflammatory Bowel Disease (IBD) Treatment Scope and Market Size
Inflammatory Bowel Disease (IBD) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease (IBD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie
Pfizer
Takeda
Janssen Biotech, Inc. (Johnson & Johnson)
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen Inc.

Market segment by Type, the product can be split into
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
1.4 Market by Type
1.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 TNF Inhibitors
1.4.3 Aminosalicyclates
1.4.4 Immunomodulators
1.4.5 Corticosteroids
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2015-2026)
2.2 Global Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Inflammatory Bowel Disease (IBD) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Inflammatory Bowel Disease (IBD) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Market Size
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2015-2020)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio
3.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2019
3.3 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.4 Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
3.5 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
6.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in North America (2019-2020)
6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
7.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
8.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in China (2019-2020)
8.3 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
8.4 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
9.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
9.4 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
10.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
11.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in India (2019-2020)
11.3 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
11.4 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
12.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction
13.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction
13.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview
13.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction
13.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Janssen Biotech, Inc. (Johnson & Johnson)
13.4.1 Janssen Biotech, Inc. (Johnson & Johnson) Company Details
13.4.2 Janssen Biotech, Inc. (Johnson & Johnson) Business Overview
13.4.3 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Introduction
13.4.4 Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.4.5 Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction
13.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 Bausch Health
13.6.1 Bausch Health Company Details
13.6.2 Bausch Health Business Overview
13.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction
13.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.6.5 Bausch Health Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview
13.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction
13.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction
13.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Biogen Inc.
13.9.1 Biogen Inc. Company Details
13.9.2 Biogen Inc. Business Overview
13.9.3 Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Introduction
13.9.4 Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.9.5 Biogen Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Inflammatory Bowel Disease (IBD) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
Table 3. Ranking of Global Top Inflammatory Bowel Disease (IBD) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of TNF Inhibitors
Table 6. Key Players of Aminosalicyclates
Table 7. Key Players of Immunomodulators
Table 8. Key Players of Corticosteroids
Table 9. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2015-2020)
Table 13. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Inflammatory Bowel Disease (IBD) Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Inflammatory Bowel Disease (IBD) Treatment Players
Table 20. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players (2015-2020)
Table 22. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2019)
Table 23. Global Inflammatory Bowel Disease (IBD) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
Table 26. Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Type (2015-2020)
Table 30. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Application (2015-2020)
Table 32. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 36. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 38. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 42. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 44. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 48. China Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 50. China Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 54. Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 56. Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 60. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 66. India Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 68. India Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Inflammatory Bowel Disease (IBD) Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Inflammatory Bowel Disease (IBD) Treatment Market Share (2019-2020)
Table 72. Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Share by Application (2015-2020)
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 85. Pfizer Recent Development
Table 86. Takeda Company Details
Table 87. Takeda Business Overview
Table 88. Takeda Product
Table 89. Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 90. Takeda Recent Development
Table 91. Janssen Biotech, Inc. (Johnson & Johnson) Company Details
Table 92. Janssen Biotech, Inc. (Johnson & Johnson) Business Overview
Table 93. Janssen Biotech, Inc. (Johnson & Johnson) Product
Table 94. Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 95. Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
Table 96. Allergan Company Details
Table 97. Allergan Business Overview
Table 98. Allergan Product
Table 99. Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 100. Allergan Recent Development
Table 101. Bausch Health Company Details
Table 102. Bausch Health Business Overview
Table 103. Bausch Health Product
Table 104. Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 105. Bausch Health Recent Development
Table 106. Takeda Pharmaceutical Company Details
Table 107. Takeda Pharmaceutical Business Overview
Table 108. Takeda Pharmaceutical Product
Table 109. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 110. Takeda Pharmaceutical Recent Development
Table 111. Novartis Business Overview
Table 112. Novartis Product
Table 113. Novartis Company Details
Table 114. Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 115. Novartis Recent Development
Table 116. Biogen Inc. Company Details
Table 117. Biogen Inc. Business Overview
Table 118. Biogen Inc. Product
Table 119. Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020) (Million US$)
Table 120. Biogen Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Type: 2020 VS 2026
Figure 2. TNF Inhibitors Features
Figure 3. Aminosalicyclates Features
Figure 4. Immunomodulators Features
Figure 5. Corticosteroids Features
Figure 6. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Inflammatory Bowel Disease (IBD) Treatment Report Years Considered
Figure 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players in 2019
Figure 16. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2019
Figure 18. North America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の炎症性腸疾患(IBD)治療市場2026:インサイト・予測] (Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2020-2026 / QYR20NV12375)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆